Teladoc Health, Inc.TDOCEarnings & Financial Report
Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company headquartered in New York, New York, United States that was founded in 2002. Primary services include telehealth, medical opinions, AI and analytics, telehealth devices and licensable platform services. In particular, Teladoc Health uses telephone and videoconferencing software as well as mobile apps to provide on-demand remote medical care.
Revenue
$631.9M
Gross Profit
N/A
Operating Profit
$-54.4M
Net Profit
$-32.7M
Gross Margin
N/A
Operating Margin
-8.6%
Net Margin
-5.2%
YoY Growth
-1.6%
EPS
$-0.19
Financial Flow
Teladoc Health, Inc. Q2 2025 Financial Summary
Teladoc Health, Inc. reported revenue of $631.9M (down 1.6% YoY) for Q2 2025, with a net profit of $-32.7M (up 96.1% YoY) (-5.2% margin). Cost of goods sold was N/A.
Key Financial Metrics
| Total Revenue | $631.9M |
|---|---|
| Net Profit | $-32.7M |
| Gross Margin | N/A |
| Operating Margin | -8.6% |
| Report Period | Q2 2025 |
Revenue Breakdown
Teladoc Health, Inc. Q2 2025 revenue of $631.9M breaks down across 2 segments, led by Subscription Access Fees at $523.7M (82.9% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Subscription Access Fees | $523.7M | 82.9% |
| Other Revenue | $108.2M | 17.1% |
Teladoc Health, Inc. Revenue by Segment — Quarterly Trend
Teladoc Health, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Subscription Access Fees and Other Revenue) has evolved quarter over quarter.
| Segment | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Subscription Access Fees | — | $520.9M | $523.7M | $525.7M |
| Other Revenue | — | $105.5M | $108.2M | $103.6M |
Teladoc Health, Inc. Annual Revenue by Year
Teladoc Health, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.5B).
| Year | Annual Revenue |
|---|---|
| 2025 | $2.5B |
| 2024 | $2.6B |
| 2023 | $2.6B |
| 2022 | $2.4B |
Teladoc Health, Inc. Quarterly Revenue & Net Profit History
Teladoc Health, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $642.3M | +0.3% | N/A | N/A |
| Q3 2025 | $626.4M | -2.2% | $-49.5M | -7.9% |
| Q2 2025 | $631.9M | -1.6% | $-32.7M | -5.2% |
| Q1 2025 | $629.4M | -2.6% | $-93.0M | -14.8% |
| Q4 2024 | $640.5M | -3.0% | N/A | N/A |
| Q3 2024 | $640.5M | -3.0% | $-33.3M | -5.2% |
| Q2 2024 | $642.4M | -1.5% | $-837.7M | -130.4% |
| Q1 2024 | $646.1M | +2.7% | $-81.9M | -12.7% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $646.1M | $642.4M | $640.5M | $640.5M | $629.4M | $631.9M | $626.4M | $642.3M |
| YoY Growth | 2.7% | -1.5% | -3.0% | -3.0% | -2.6% | -1.6% | -2.2% | 0.3% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $4.32B | $3.52B | $3.53B | $3.52B | $3.44B | $2.89B | $2.88B | $2.86B |
| Liabilities | $2.03B | $2.02B | $2.02B | $2.03B | $2.02B | $1.47B | $1.49B | $1.47B |
| Equity | $2.29B | $1.50B | $1.51B | $1.49B | $1.43B | $1.42B | $1.39B | $1.39B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $8.9M | $88.7M | $110.2M | $85.9M | $15.9M | $91.4M | $99.3M | $87.7M |